| Literature DB >> 35581547 |
Qian Ma1, Jingjing Ji1, Xueduo Shi1, Ziyun Lu1, Lu Xu1, Jing Hao1, Wei Zhu1, Bingbing Li2.
Abstract
BACKGROUND: The volume status of patients after major abdominal surgery constantly varies owing to postoperative diverse issues comprising fluid loss or capillary leakage secondary to systemic inflammatory reaction syndrome, et.al, the precise fluid responsiveness assessment is crucial for those patients. The purpose of this study is to validate the transthoracic ultrasonographic measurement of superior and inferior vena cava variation in predicting fluid responsiveness of mechanically ventilated patients after surgery.Entities:
Keywords: Fluid responsiveness; Inferior vena cava distensibility index; Superior vena cava cardiac variation; Superior vena cava collapsibility index; Transthoracic ultrasonography
Mesh:
Year: 2022 PMID: 35581547 PMCID: PMC9112503 DOI: 10.1186/s12871-022-01692-8
Source DB: PubMed Journal: BMC Anesthesiol ISSN: 1471-2253 Impact factor: 2.376
Fig. 1M-mode visualization of the superior vena cava (SVC) measured with transthoracic echocardiography showing the maximal (SVCmax1) and minimal (SVCmin1) diameters over the respirophasic cycle and maximal (SVCmax2) and minimal (SVCmin2) diameters over the cardiac cycle
Baseline demographic and intraoperative data of patients responding to fluid challenge or not
| Variable | All patients ( | Responder ( | Non-responder ( | |
|---|---|---|---|---|
| Age (yr) | 61 (52–68) | 61 ± 9 | 63 (51–70) | 0.891 |
| Female (n, %) | 34 (48.6) | 18 (60) | 16 (40) | 0.098 |
| BMI (kg m−2) | 23.24 ± 1.64 | 23.14 ± 1.61 | 23.32 ± 1.69 | 0.668 |
| BSA (m2) | 1.65 ± 0.13 | 1.62 ± 0.12 | 1.67 ± 0.13 | 0.164 |
| ASA (III, %) | 59 ± 84.3 | 27 ± 90 | 32 ± 10 | 0.420 |
| Medical history | ||||
| Hypertension | 19 (27.1) | 14 (46.7) | 15 (37.5) | 0.441 |
| Diabetes mellitus (n, %) | 10 (14.3) | 6 (20) | 4 (10) | 0.402 |
| History of coronary artery disease (n, %) | 2 (2.9) | 0 (0) | 2 (5) | 0.503 |
| History of cerebrovascular artery disease (n, %) | 5 (7.1) | 3 (10) | 2 (5) | 0.645 |
| Surgey duration (h) | 3.46 (2.71–4.23) | 3.63 (2.75–4.81) | 3.42 (2.62–4.06) | 0.458 |
| Fluid infusion (ml) | 2000 (2000–2600) | 2250 (2000–2850) | 2000 (1575–2500) | 0.224 |
| Estimated blood loss (ml) | 200 (100–300) | 200 (100–325) | 200 (100–300) | 0.775 |
| Urine output (ml) | 500 (275–800) | 600 (200–938) | 400 (300–650) | 0.220 |
| Use of intraoperative vascular active agents (n, %) | 13 (18.6) | 4 (13.3) | 9 (22.5) | 0.329 |
| Types of surgery | 0.093 | |||
| Radical resection of hepatobiliary and pancreatic tumors | 29 (41.4) | 15 (50) | 14 (35) | |
| Radical resection of gastrointestinal tumors | 25 (35.7) | 11 (36.7) | 14 (35) | |
| Radical resection of urological tumors | 11 (15.7) | 2 (6.7) | 9 (22.5) | |
| Others | 5 (7.1) | 2 (6.7) | 3 (7.5) | |
BMI Body mass index, BSA Body surface area, ASA American Society of Anesthesiologists physical status
Main hemodynamic and ultrasonographic parameters between responders and non-responders at baseline and after volume expansion
| Parameters | Time Point | Resonder ( | Nonresponder ( | |
|---|---|---|---|---|
| MAP (mmHg) | T0 | 91 ± 13 | 90 ± 11 | 0.829 |
| T1 | 94 ± 15 | 92 ± 11 | 0.506 | |
| CVP (cmH2O) | T0 | 6 ± 2 | 6 ± 2 | 0.848 |
| T1 | 7 ± 2† | 7 ± 3† | 0.774 | |
| HR (beats min−1) | T0 | 62 ± 11 | 60 ± 9 | 0.346 |
| T1 | 64 ± 10† | 59 ± 8† | 0.013 | |
| VTI (cm) | T0 | 20.8 ± 3.4 | 22.3 ± 3.3 | 0.054 |
| T1 | 24.3 ± 3.4† | 23.3 ± 3.7† | 0.286 | |
| CO (L min−1) | T0 | 3.9 (3.5–4.6) | 4.3 ± 1.0 | 0.455 |
| T1 | 4.7 (4.2–5.6) † | 4.4 ± 1.0† | 0.02 | |
| SVCCI | T0 | 0.33 ± 0.11 | 0.16 (0.12–0.21) | < 0.001 |
| T1 | 0.29 ± 0.09 | 0.17 ± 0.08 | < 0.001 | |
| dIVC | T0 | 0.20 (0.16–0.35) | 0.13 (0.08–0.21) | 0.001 |
| T1 | 0.22 (0.14–0.33) | 0.12 (0.07–0.19) | 0.002 | |
| SVCV | T0 | 0.18 (0.13–0.29) | 0.11 (0.07–0.15) | < 0.001 |
| T1 | 0.20 (0.14–0.28) | 0.13 ± 0.08 | < 0.001 |
†P < 0.05 versus before fluid challenge test. T0, Before fluid challenge; T1, After fluid challenge; P-value corresponds to the comparison between Responders and Nonresponders
Diagnostic capability of dynamic parameters to predict fluid responsiveness
| Parameters | AUC curve (95% CI) | Optimal cut-off value | Sensitivity (%) (95% CI) | Specificity (%) (95% CI) | Youden index | Gray zones | Patients in gray zones (%) | |
|---|---|---|---|---|---|---|---|---|
| SVCCI | 0.885 (0.786–0.949) | < 0.0001 | > 0.19 | 93.3 (77.9–99.2) | 75 (58.8–87. 3) | 0.683 | 0.2–0.25 | 11 (15.7) |
| dIVC* | 0.727 (0.608–0.827) | 0.0003 | > 0.14 | 80 (61.4–92.3) | 62.5 (45.8–77.3) | 0.425 | 0.07–0.27 | 44 (62.9) |
| SVCV* | 0.751 (0.633–0.847) | < 0.0001 | > 0.15 | 60 (40.6–77.3) | 80 (64.4–90.9) | 0.4 | 0.09–0.21 | 35 (50) |
*SVCCI versus dIVC, P = 0.0369; SVCCI versus SVCV, P = 0.0372
Fig. 2Receiver operating characteristic curves comparing the ability of superior vena caval collapsibility index (SVCCI), inferior vena cava distensibility index (dIVC), and superior vena caval variation over the cardiac cycle (SVCV) (A) to discriminate responders from nonresponders. Sensitivity and specificity plots predict fluid responsiveness according to the values of SVCCI (B), dIVC (C), and SVCV (D) to determine the gray zone which is indicated by the two vertical dotted lines